* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Patients thrilled with therapy's results

Bio-identical hormone pellets used by men are a bit larger than those for women. Like any emerging medical therapy, there are plenty of questions about bio-identical hormone replacement and methods such as SottoPelle pellets. The U.S. Food and Drug Administration does not acknowledge the term "bio-identical," and has not evaluated or approved the safety, testing, side effects or manufacturing of any bio-identical hormone replacement therapy (BHRT) drugs. In January, the agency issued warning letters to seven pharmacies that produce BHRT drugs, saying that "the claims they make about the safety and effectiveness of their so-called 'bio-identical hormone replacement therapy,' or 'BHRT' products, are unsupported by medical evidence, and are considered false and misleading by the agency." Solutions Pharmacy, the Tennessee-based... [read full story]                    

Add Comment
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies